First Time Loading...
I

Ilyang Pharmaceutical Co Ltd
KRX:007570

Watchlist Manager
Ilyang Pharmaceutical Co Ltd
KRX:007570
Watchlist
Price: 13 900 KRW 0.22% Market Closed
Updated: May 15, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

370.5B
+0.8%
Revenue
Growth Rates:
1 Year
-3%
3 Years
+8%
5 Years
+23%
7 Years
+42%
10 Years
+226%
24.8B
+10%
Operating Income
Growth Rates:
1 Year
-39%
3 Years
-27%
5 Years
+48%
7 Years
+7%
10 Years
+759%
-2.5B
Net Income
Growth Rates:
1 Year
-
3 Years
-
5 Years
+48%
7 Years
-
10 Years
-

Earnings Waterfall
Ilyang Pharmaceutical Co Ltd

Revenue
370.5B KRW
Cost of Revenue
-170.4B KRW
Gross Profit
200.1B KRW
Operating Expenses
-175.3B KRW
Operating Income
24.8B KRW
Other Expenses
-27.4B KRW
Net Income
-2.5B KRW

Income Statement
Ilyang Pharmaceutical Co Ltd

Rotate your device to view
Income Statement
Currency: KRW
Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Revenue
Revenue
113 657
N/A
113 058
-1%
158 829
+40%
179 412
+13%
195 871
+9%
211 798
+8%
227 013
+7%
237 725
+5%
186 285
-22%
244 667
+31%
245 452
+0%
257 986
+5%
261 615
+1%
263 158
+1%
262 323
0%
262 213
0%
269 811
+3%
282 462
+5%
291 973
+3%
289 460
-1%
300 036
+4%
304 435
+1%
311 322
+2%
323 111
+4%
324 573
+0%
319 241
-2%
324 142
+2%
336 954
+4%
343 329
+2%
353 772
+3%
353 265
0%
351 562
0%
371 348
+6%
374 957
+1%
376 539
+0%
389 454
+3%
383 811
-1%
378 437
-1%
380 654
+1%
367 432
-3%
370 537
+1%
Gross Profit
Cost of Revenue
(67 663)
(66 338)
(91 998)
(104 811)
(113 164)
(118 544)
(126 176)
(134 214)
(102 470)
(130 570)
(129 606)
(137 349)
(138 179)
(137 980)
(133 397)
(128 388)
(133 633)
(136 910)
(140 592)
(136 487)
(145 742)
(147 667)
(147 217)
(151 105)
(145 802)
(144 886)
(148 742)
(158 522)
(161 620)
(165 967)
(166 813)
(159 334)
(166 945)
(165 330)
(161 553)
(168 207)
(167 783)
(170 966)
(174 253)
(168 257)
(170 389)
Gross Profit
45 993
N/A
46 719
+2%
66 830
+43%
74 600
+12%
82 707
+11%
93 254
+13%
100 838
+8%
103 511
+3%
83 816
-19%
114 097
+36%
115 846
+2%
120 638
+4%
123 436
+2%
125 180
+1%
128 927
+3%
133 826
+4%
136 178
+2%
145 553
+7%
151 382
+4%
152 973
+1%
154 294
+1%
156 767
+2%
164 105
+5%
172 007
+5%
178 771
+4%
174 356
-2%
175 400
+1%
178 432
+2%
181 709
+2%
187 805
+3%
186 452
-1%
192 228
+3%
204 403
+6%
209 627
+3%
214 986
+3%
221 247
+3%
216 028
-2%
207 471
-4%
206 402
-1%
199 175
-4%
200 148
+0%
Operating Income
Operating Expenses
(43 105)
(43 050)
(63 046)
(71 349)
(79 882)
(87 008)
(88 697)
(89 058)
(68 299)
(91 296)
(94 814)
(96 900)
(100 253)
(103 928)
(106 277)
(110 248)
(111 745)
(118 612)
(124 944)
(130 476)
(137 572)
(138 900)
(143 560)
(144 722)
(146 261)
(144 709)
(145 986)
(146 548)
(147 608)
(154 271)
(152 345)
(157 026)
(163 378)
(165 722)
(168 309)
(174 042)
(175 621)
(173 682)
(178 683)
(176 533)
(175 335)
Selling, General & Administrative
(40 457)
(34 318)
(52 297)
(59 042)
(67 620)
(77 653)
(74 877)
(75 355)
(60 459)
(80 693)
(83 972)
(86 097)
(89 414)
(92 377)
(95 030)
(98 579)
(98 740)
(105 102)
(110 893)
(114 815)
(123 449)
(125 337)
(126 985)
(129 079)
(129 395)
(125 169)
(126 977)
(125 814)
(126 835)
(132 567)
(132 386)
(137 161)
(142 438)
(142 822)
(145 071)
(148 411)
(148 445)
(145 601)
(148 987)
(147 228)
(146 710)
Research & Development
(958)
(7 041)
(8 831)
(10 971)
(10 668)
(8 361)
(12 303)
(12 124)
(7 161)
(9 660)
(9 890)
(10 025)
(10 113)
(10 244)
(9 993)
(10 405)
(12 387)
(12 889)
(13 408)
(15 045)
(12 844)
(12 167)
(15 086)
(14 046)
(15 850)
(18 555)
(18 065)
(19 833)
(19 723)
(18 720)
(18 823)
(18 648)
(20 196)
(22 009)
(22 402)
(24 736)
(25 960)
(26 792)
(28 451)
(28 106)
(27 439)
Depreciation & Amortization
(1 690)
0
(1 917)
(1 335)
(1 593)
(994)
(1 517)
(1 579)
(679)
(882)
(919)
(778)
(727)
(669)
(615)
(628)
(618)
(621)
(644)
(618)
(1 279)
(1 395)
(1 488)
(1 596)
(1 016)
(985)
(954)
(901)
(1 050)
(1 037)
(1 198)
(1 279)
(744)
(959)
(844)
(903)
(1 216)
(1 289)
(1 245)
(1 198)
(1 186)
Other Operating Expenses
0
(1 691)
0
0
0
0
0
0
0
(61)
(33)
0
0
(638)
(639)
(636)
0
0
0
0
0
0
0
0
0
0
10
0
0
(1 947)
61
61
0
68
7
7
0
0
0
0
0
Operating Income
2 889
N/A
3 671
+27%
3 786
+3%
3 253
-14%
2 826
-13%
6 246
+121%
12 140
+94%
14 452
+19%
15 516
+7%
22 799
+47%
21 030
-8%
23 736
+13%
23 183
-2%
21 250
-8%
22 649
+7%
23 577
+4%
24 433
+4%
26 941
+10%
26 438
-2%
22 498
-15%
16 722
-26%
17 869
+7%
20 546
+15%
27 285
+33%
32 511
+19%
29 646
-9%
29 413
-1%
31 883
+8%
34 101
+7%
33 534
-2%
34 108
+2%
35 203
+3%
41 025
+17%
43 905
+7%
46 677
+6%
47 205
+1%
40 408
-14%
33 789
-16%
27 719
-18%
22 642
-18%
24 813
+10%
Pre-Tax Income
Interest Income Expense
(88)
1 366
(770)
(3 784)
(4 387)
(8 569)
(8 152)
(7 043)
(4 890)
(6 653)
(6 032)
(5 809)
(5 567)
(5 033)
(5 106)
(4 948)
(5 193)
(4 794)
(4 389)
(4 535)
(3 837)
(4 007)
(4 340)
(3 928)
(4 108)
(3 477)
(3 522)
(3 438)
(3 542)
(2 906)
(2 075)
(1 031)
(167)
23
441
85
(1 768)
(3 357)
(4 745)
(5 501)
(4 353)
Non-Reccuring Items
0
0
0
0
0
(708)
(736)
(754)
(61)
0
0
(19)
(639)
0
0
0
0
0
0
0
0
0
(10)
0
0
0
0
0
(1 947)
0
(1 708)
(1 708)
293
493
269
203
(26)
(160)
(2 109)
(2 049)
(16 460)
Gain/Loss on Disposition of Assets
0
32
0
0
0
64
70
73
9
0
0
0
0
3
13
13
14
0
0
0
0
0
(504)
(508)
(507)
0
134
0
134
135
(33)
(33)
(26)
0
5
6
21
21
20
20
1
Total Other Income
(384)
(52)
716
1 720
(108)
307
(371)
(696)
879
923
1 202
912
(738)
(670)
(1 099)
(863)
(1 046)
(960)
(855)
(660)
(4 816)
(4 911)
(4 817)
(5 387)
(235)
(776)
(481)
149
(354)
(3 202)
(2 291)
(2 249)
(2 197)
1 402
631
2 564
2 696
3 124
2 852
468
(952)
Pre-Tax Income
2 416
N/A
5 015
+108%
3 732
-26%
1 189
-68%
(1 669)
N/A
(2 660)
-59%
2 951
N/A
6 031
+104%
11 453
+90%
17 069
+49%
16 200
-5%
18 820
+16%
16 238
-14%
15 552
-4%
16 458
+6%
17 779
+8%
18 207
+2%
21 187
+16%
21 193
+0%
17 303
-18%
8 069
-53%
8 950
+11%
10 875
+22%
17 462
+61%
27 661
+58%
25 393
-8%
25 544
+1%
28 594
+12%
28 393
-1%
27 559
-3%
28 001
+2%
30 180
+8%
38 927
+29%
45 822
+18%
48 023
+5%
50 062
+4%
41 331
-17%
33 417
-19%
23 737
-29%
15 581
-34%
3 048
-80%
Net Income
Tax Provision
(183)
(1 439)
(2 745)
(3 568)
(3 221)
(2 997)
(2 014)
(2 847)
(3 149)
(4 652)
(5 084)
(4 262)
(4 275)
(4 154)
(3 853)
(6 586)
(5 266)
(5 183)
(5 452)
(2 613)
(4 818)
(4 976)
(7 189)
(7 789)
(8 066)
(7 843)
(6 651)
(7 904)
(6 847)
(7 988)
(7 309)
(7 349)
(12 972)
(13 472)
(14 339)
(15 077)
(9 590)
(8 330)
(7 896)
(5 947)
(2 936)
Income from Continuing Operations
2 233
3 577
989
(2 377)
(4 888)
(5 657)
937
3 183
8 304
12 416
11 115
14 558
11 963
11 397
12 604
11 193
12 941
16 004
15 741
14 689
3 251
3 976
3 688
9 676
19 595
17 552
18 895
20 692
21 545
19 572
20 693
22 832
25 956
32 350
33 684
34 985
31 741
25 087
15 841
9 634
112
Income to Minority Interest
0
0
(1 520)
(2 943)
(4 304)
(5 305)
(5 379)
(5 449)
(4 686)
(6 377)
(5 971)
(6 086)
(6 057)
(6 132)
(6 445)
(6 659)
(6 677)
(6 865)
(7 266)
(7 719)
(8 144)
(8 797)
(8 826)
(8 972)
(9 610)
(9 057)
(9 407)
(10 132)
(10 666)
(11 526)
(11 965)
(11 271)
(11 572)
(12 341)
(12 450)
(13 725)
(12 503)
(8 960)
(6 957)
(3 679)
(2 658)
Net Income (Common)
2 233
N/A
3 577
+60%
(531)
N/A
(5 320)
-902%
(9 192)
-73%
(10 962)
-19%
(4 442)
+59%
(2 266)
+49%
3 618
N/A
6 040
+67%
5 144
-15%
8 472
+65%
5 906
-30%
5 264
-11%
6 159
+17%
4 533
-26%
6 265
+38%
9 138
+46%
8 474
-7%
6 970
-18%
(4 893)
N/A
(4 821)
+1%
(5 138)
-7%
704
N/A
9 985
+1 318%
8 493
-15%
9 486
+12%
10 558
+11%
10 880
+3%
8 045
-26%
8 727
+8%
11 559
+32%
14 384
+24%
20 009
+39%
21 234
+6%
21 260
+0%
19 238
-10%
16 128
-16%
8 884
-45%
5 955
-33%
(2 546)
N/A
EPS (Diluted)
131.35
N/A
210.41
+60%
-31.23
N/A
-312.94
-902%
-540.7
-73%
-644.82
-19%
-261.29
+59%
-125.88
+52%
201
N/A
335.55
+67%
285.77
-15%
470.66
+65%
328.11
-30%
292.44
-11%
342.16
+17%
251.83
-26%
348.05
+38%
507.66
+46%
470.77
-7%
387.22
-18%
-271.83
N/A
-267.83
+1%
-285.44
-7%
39.11
N/A
554.72
+1 318%
471.83
-15%
527
+12%
586.55
+11%
604.44
+3%
446.94
-26%
479.39
+7%
634.96
+32%
790.09
+24%
1 099.36
+39%
1 171.32
+7%
1 175.46
+0%
1 061.38
-10%
891.67
-16%
492.32
-45%
331.3
-33%
-141.29
N/A

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.